The role of glucocorticoids in the development of insulin resistence in the obese Zucker rat
The role of glucocorticoids in the development of insulin resistence in the obese Zucker rat
The obese Zucker rat, when homozygous for the recessive `fa' gene displays obesity, hyperphagia, insulin resistance and hyperinsulinaemia and is regarded as an animal model of human type II diabetes/obesity. The development of obesity in the obese rat is dependent on glucocorticoids; adrenalectomy normalises body weight gain. Administration of exogenous glucocorticoids to adrenalectomised animals will restore the body weight gain. The aim of my project was to determine whether glucocorticoids are acting on the central nervous sytem or on peripheral tissues to promote obesity in the Zucker rat. Initial work comprised the development of methods for measuring the insulin sensitivity of glucose clearance and insulin secretion in anaesthetised rats. Adult obese Zucker rats showed decreased metabolic clearance rates of glucose during hyperinsulinaemic clamp and a hypersecretion of insulin in response to a glucose load when compared to lean animals. Pretreatment of obese rats with the cholinergic blocker atropine and adrenalectomy reduced the increase in plasma insulin following a glucose load. Both treatments were without effect in lean rats. Atropine pretreatment of adrenalectomised obese rats did not reduce the post-glucose plasma insulin levels further. Insulin-stimulated metabolic clearance rates of glucose in obese rats were increased by adrenalectomy. Chronic peripheral treatment of adrenalectomised obese rats with corticosterone restored the hypersecretion of insulin following a glucose load. Chronic peripheral treatment of adult obese rats with the glucocorticoid antagonist RU 486 also reduced insulin secretion. Administration of small doses of glucocorticoid analogue dexamethasone chronically into the third ventrical of adrenalectomised obese rats increased the levels of plasma insulin following glucose load compared to saline infused controls. Atropine pretreatment of adrenalectomised dexamethasone infused obese rats before glucose administration reduced plasma insulin levels to control values. These results suggest that there is a central oversensitivity to glucocorticoids in the obese Zucker rat.
University of Southampton
Stubbs, Mark
3f77c4e1-904c-46b7-8d85-92ed6da71d3e
1991
Stubbs, Mark
3f77c4e1-904c-46b7-8d85-92ed6da71d3e
Stubbs, Mark
(1991)
The role of glucocorticoids in the development of insulin resistence in the obese Zucker rat.
University of Southampton, Doctoral Thesis.
Record type:
Thesis
(Doctoral)
Abstract
The obese Zucker rat, when homozygous for the recessive `fa' gene displays obesity, hyperphagia, insulin resistance and hyperinsulinaemia and is regarded as an animal model of human type II diabetes/obesity. The development of obesity in the obese rat is dependent on glucocorticoids; adrenalectomy normalises body weight gain. Administration of exogenous glucocorticoids to adrenalectomised animals will restore the body weight gain. The aim of my project was to determine whether glucocorticoids are acting on the central nervous sytem or on peripheral tissues to promote obesity in the Zucker rat. Initial work comprised the development of methods for measuring the insulin sensitivity of glucose clearance and insulin secretion in anaesthetised rats. Adult obese Zucker rats showed decreased metabolic clearance rates of glucose during hyperinsulinaemic clamp and a hypersecretion of insulin in response to a glucose load when compared to lean animals. Pretreatment of obese rats with the cholinergic blocker atropine and adrenalectomy reduced the increase in plasma insulin following a glucose load. Both treatments were without effect in lean rats. Atropine pretreatment of adrenalectomised obese rats did not reduce the post-glucose plasma insulin levels further. Insulin-stimulated metabolic clearance rates of glucose in obese rats were increased by adrenalectomy. Chronic peripheral treatment of adrenalectomised obese rats with corticosterone restored the hypersecretion of insulin following a glucose load. Chronic peripheral treatment of adult obese rats with the glucocorticoid antagonist RU 486 also reduced insulin secretion. Administration of small doses of glucocorticoid analogue dexamethasone chronically into the third ventrical of adrenalectomised obese rats increased the levels of plasma insulin following glucose load compared to saline infused controls. Atropine pretreatment of adrenalectomised dexamethasone infused obese rats before glucose administration reduced plasma insulin levels to control values. These results suggest that there is a central oversensitivity to glucocorticoids in the obese Zucker rat.
This record has no associated files available for download.
More information
Published date: 1991
Identifiers
Local EPrints ID: 462008
URI: http://eprints.soton.ac.uk/id/eprint/462008
PURE UUID: 3595cbbc-154f-4167-8d56-b41486f18d44
Catalogue record
Date deposited: 04 Jul 2022 18:59
Last modified: 23 Jul 2022 00:34
Export record
Contributors
Author:
Mark Stubbs
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics